Form D · Biotechnology
CANCER GENETICS, INC
Rutherford, NJ · CIK 0001349929
Offering snapshot reported Feb 3, 2021 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2021 | Initial | $10,000,000 | No comparison | 6 | SEC filing |
| Mar 27, 2017 | Initial | $6,000,000 | No comparison | 3 | SEC filing |
| Dec 5, 2016 | Initial | $5,500,000 | No comparison | 16 | SEC filing |
| May 25, 2016 | Initial | $5,000,000 | No comparison | 41 | SEC filing |
| Nov 1, 2010 | Amendment | $6,618,000 | $0vs Sep 27, 2010 | 42 | SEC filing |
| Sep 27, 2010 | Initial | $6,618,000 | No comparison | 42 | SEC filing |
| Dec 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $775K
- Finders' fees
- $0
- Form D file number
- 021-388238
Excludes the value of up to 165,517 warrants issued to the Placement Agent exercisable at $4.5313 per share.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Feb 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edmund Cannon | Director |
| Raju S.K. Chaganti | Director |
| Riccardo Dalla Favera | Director |
| Geoffrey Harris | Director |
| Howard Mc Leod | Director |
| John Pappajohn | Director |
| Andrew Pecora | Director |
| Franklyn G. Prendergast | Director |
| John A. Roberts | Executive |
| Panna L. Sharma | Director, Executive |
| Edward Sitar | Executive |
| Tommy Thompson | Director |
| Michael J. Welsh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 Route 17 North 2 Nd Floor
Rutherford, NJ, 07070
Rutherford, NJ, 07070